Posted by Michael Wonder on 28 Apr 2025
New position statement aims to guide the use of AI methods in health technology assessment
25 April 2025 - Canada’s Drug Agency has published a new position statement on the use of artificial intelligence methods in health technology assessment.
The work of Canada’s Drug Agency is grounded in the independent assessment and evaluation of evidence, which is provided to health system leaders along with expert advice, enabling them to make informed decisions on drugs, health technologies, and health systems.
